Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: the RIETECAT study - Trujillo-Santos, J; Farge-Bancel, D; Pedrajas, J M; RIETE Investigators (Res Pract Thromb Haemost, 2022)